SlideShare a Scribd company logo
1 of 17
The Role of Maintenance Therapy
in Lymphoma

Arnie Freedman, M.D.
Clinical Director, Dana-Farber/Brigham and Women’s
Cancer Center Adult Lymphoma Program
Maintenance
the process of maintaining or
preserving someone or something,
or the state of being maintained.

synonyms: preservation,
conservation, keeping,
prolongation, perpetuation, carry
on, continuation.
Maintenance therapy for lymphoma
Use an effective therapy after remission is
attained, to maintain that remission and
hopefully increase survival, without increased
toxicity, both early and late.
Maintenance therapy
What is the goal ?
maintaining remission
improving survival
What disease ?

What drug to use ?
Maintenance therapy
What are the endpoints and what disease ?
(goals: remission, survival, both)
For aggressive disease, remission and
survival easier to demonstrate.
For indolent disease, survival benefit
harder to prove.
Maintenance therapy
What drug to use ?

has to be effective by itself against
the disease.
benefits have to outweigh the side
effects and risks.
Drug choices
Has anyone taken chlorambucil for long time?

Chemotherapy (chlorambucil)
Pros
effective agent, convenient (oral), no hair
loss, minimal nausea.
Cons:
lowers blood counts, toxic to stem cells,
risk of malignancy (solid tumor, leukemia).
Drug choices
Has anyone taken interferon ?

Interferon-a
Pros
“immunotherapy”
Cons:
minimal anti-lymphoma activity, some
inconvenience (inject), flu like symptoms
Drug choices
Raise your hand if you have had rituximab
maintenance ?
Rituximab
Pros
effective agent, some inconvenience (I.V.)

Cons:
infusion reactions, infection risk
Maintenance studies (randomized)
Past
CLL, follicular NHL (chemotherapy,
interferon)
Present
DLBCL, follicular NHL, MCL (rituximab)
Future
DLBCL, Hodgkin’s, others (small
molecules, antibody-drug conjugates)
Maintenance: the past
Chlorambucil maintenance for CLL
No advantage in survival

Myelosuppression
More second malignancies
(AML/MDS/solid tumors)
Maintenance: the past
Interferon maintenance for follicular NHL

Chemotherapy followed by maintenance
or none.
Longer remissions, no advantage in
survival.
Poor tolerance, compliance.
Never adopted in U.S.A.
Maintenance: the present
Rituximab maintenance for follicular NHL

Longer remissions after chemotherapy,
chemoimmunotherapy, rituximab alone.
No increased survival (yet).
Reasonably well tolerated, increased viral
infections.
Well adopted in U.S.A.
Maintenance: the present
Rituximab maintenance for DLBCL, MCL.

For MCL but not DLBCL, longer
remissions after chemoimmunotherapy.
Improved survival for MCL.
Well tolerated, but maintenance is
indefinite (MCL study).
Maintenance: the future
Should maintenance be pursued?
Generally has not worked well (rituximab is the
exception).
Wrong drug choice, wrong disease, hard to

study (compliance and safety).

Will new effective drugs work as maintenance?
ADC (brentuximab), oral kinase inhibitors
Maintenance: the future
Enzastaurin (oral kinase inhibitor)
Maintenance for DLBCL
No benefit
Marginally effective drug
Induction prior to maintenance more
effective than in past.
Maintenance: the future
Brentuximab (antibody drug conjugate)
Maintenance for Hodgkin lymphoma post
autoSCT.

Oral kinase inhibitors being studied
for example, idelalisib for follicular NHL

More Related Content

What's hot

What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...
What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...
What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...Dana-Farber Cancer Institute
 
Triple Negative Breast Cancer and Women of Color (Slide 2)
Triple Negative Breast Cancer and Women of Color (Slide 2)Triple Negative Breast Cancer and Women of Color (Slide 2)
Triple Negative Breast Cancer and Women of Color (Slide 2)bkling
 
Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016
Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016
Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016Dana-Farber Cancer Institute
 
Clinical Trials, Emerging New Drugs and Future Concepts in the Treatment of L...
Clinical Trials, Emerging New Drugs and Future Concepts in the Treatment of L...Clinical Trials, Emerging New Drugs and Future Concepts in the Treatment of L...
Clinical Trials, Emerging New Drugs and Future Concepts in the Treatment of L...Dana-Farber Cancer Institute
 
Triple-Negative Breast Cancer: 2018 Status Update
Triple-Negative Breast Cancer: 2018 Status UpdateTriple-Negative Breast Cancer: 2018 Status Update
Triple-Negative Breast Cancer: 2018 Status UpdateZeena Nackerdien
 
Making Progress in the Treatment of Estrogen Receptor Positive Metastatic Bre...
Making Progress in the Treatment of Estrogen Receptor Positive Metastatic Bre...Making Progress in the Treatment of Estrogen Receptor Positive Metastatic Bre...
Making Progress in the Treatment of Estrogen Receptor Positive Metastatic Bre...Dana-Farber Cancer Institute
 
Treating Pain and Neuropathy in Metastatic Breast Cancer
Treating Pain and Neuropathy in Metastatic Breast Cancer Treating Pain and Neuropathy in Metastatic Breast Cancer
Treating Pain and Neuropathy in Metastatic Breast Cancer Dana-Farber Cancer Institute
 
Hr+ her2 neu mbc
Hr+ her2 neu   mbcHr+ her2 neu   mbc
Hr+ her2 neu mbcmadurai
 
What's New in Research for ER+ Metastatic Breast Cancer
What's New in Research for ER+ Metastatic Breast CancerWhat's New in Research for ER+ Metastatic Breast Cancer
What's New in Research for ER+ Metastatic Breast CancerDana-Farber Cancer Institute
 
MCO 2011 - Slide 12 - J. Gligorov - Spotlight session - Triple negative breas...
MCO 2011 - Slide 12 - J. Gligorov - Spotlight session - Triple negative breas...MCO 2011 - Slide 12 - J. Gligorov - Spotlight session - Triple negative breas...
MCO 2011 - Slide 12 - J. Gligorov - Spotlight session - Triple negative breas...European School of Oncology
 
A Researcher's Perspective: Myths & Facts about Triple Negative Breast Cancer...
A Researcher's Perspective: Myths & Facts about Triple Negative Breast Cancer...A Researcher's Perspective: Myths & Facts about Triple Negative Breast Cancer...
A Researcher's Perspective: Myths & Facts about Triple Negative Breast Cancer...Breast Health Collaborative of Texas
 
Triple Negative Breast Cancer
Triple Negative Breast CancerTriple Negative Breast Cancer
Triple Negative Breast CancerMohamed Abdulla
 
Rehabilitation Issues in Breast Cancer Survivorship
Rehabilitation Issues in Breast Cancer SurvivorshipRehabilitation Issues in Breast Cancer Survivorship
Rehabilitation Issues in Breast Cancer SurvivorshipOSUCCC - James
 
Side Effects Management for the Ovarian Cancer Community
Side Effects Management for the Ovarian Cancer CommunitySide Effects Management for the Ovarian Cancer Community
Side Effects Management for the Ovarian Cancer Communitybkling
 
triple negative breast cancer
triple negative breast cancertriple negative breast cancer
triple negative breast cancerLuis Toache
 

What's hot (18)

Targeting Advanced Triple-Negative Breast Cancer
Targeting Advanced Triple-Negative Breast CancerTargeting Advanced Triple-Negative Breast Cancer
Targeting Advanced Triple-Negative Breast Cancer
 
What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...
What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...
What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...
 
Triple Negative Breast Cancer and Women of Color (Slide 2)
Triple Negative Breast Cancer and Women of Color (Slide 2)Triple Negative Breast Cancer and Women of Color (Slide 2)
Triple Negative Breast Cancer and Women of Color (Slide 2)
 
Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016
Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016
Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016
 
Clinical Trials, Emerging New Drugs and Future Concepts in the Treatment of L...
Clinical Trials, Emerging New Drugs and Future Concepts in the Treatment of L...Clinical Trials, Emerging New Drugs and Future Concepts in the Treatment of L...
Clinical Trials, Emerging New Drugs and Future Concepts in the Treatment of L...
 
Triple-Negative Breast Cancer: 2018 Status Update
Triple-Negative Breast Cancer: 2018 Status UpdateTriple-Negative Breast Cancer: 2018 Status Update
Triple-Negative Breast Cancer: 2018 Status Update
 
Making Progress in the Treatment of Estrogen Receptor Positive Metastatic Bre...
Making Progress in the Treatment of Estrogen Receptor Positive Metastatic Bre...Making Progress in the Treatment of Estrogen Receptor Positive Metastatic Bre...
Making Progress in the Treatment of Estrogen Receptor Positive Metastatic Bre...
 
Treating Pain and Neuropathy in Metastatic Breast Cancer
Treating Pain and Neuropathy in Metastatic Breast Cancer Treating Pain and Neuropathy in Metastatic Breast Cancer
Treating Pain and Neuropathy in Metastatic Breast Cancer
 
Hr+ her2 neu mbc
Hr+ her2 neu   mbcHr+ her2 neu   mbc
Hr+ her2 neu mbc
 
What's New in Research for ER+ Metastatic Breast Cancer
What's New in Research for ER+ Metastatic Breast CancerWhat's New in Research for ER+ Metastatic Breast Cancer
What's New in Research for ER+ Metastatic Breast Cancer
 
MCO 2011 - Slide 12 - J. Gligorov - Spotlight session - Triple negative breas...
MCO 2011 - Slide 12 - J. Gligorov - Spotlight session - Triple negative breas...MCO 2011 - Slide 12 - J. Gligorov - Spotlight session - Triple negative breas...
MCO 2011 - Slide 12 - J. Gligorov - Spotlight session - Triple negative breas...
 
How to Manage Chemobrain
How to Manage ChemobrainHow to Manage Chemobrain
How to Manage Chemobrain
 
A Researcher's Perspective: Myths & Facts about Triple Negative Breast Cancer...
A Researcher's Perspective: Myths & Facts about Triple Negative Breast Cancer...A Researcher's Perspective: Myths & Facts about Triple Negative Breast Cancer...
A Researcher's Perspective: Myths & Facts about Triple Negative Breast Cancer...
 
Triple Negative Breast Cancer
Triple Negative Breast CancerTriple Negative Breast Cancer
Triple Negative Breast Cancer
 
Metastatic Breast Cancer Research and Treatment
Metastatic Breast Cancer Research and TreatmentMetastatic Breast Cancer Research and Treatment
Metastatic Breast Cancer Research and Treatment
 
Rehabilitation Issues in Breast Cancer Survivorship
Rehabilitation Issues in Breast Cancer SurvivorshipRehabilitation Issues in Breast Cancer Survivorship
Rehabilitation Issues in Breast Cancer Survivorship
 
Side Effects Management for the Ovarian Cancer Community
Side Effects Management for the Ovarian Cancer CommunitySide Effects Management for the Ovarian Cancer Community
Side Effects Management for the Ovarian Cancer Community
 
triple negative breast cancer
triple negative breast cancertriple negative breast cancer
triple negative breast cancer
 

Viewers also liked

Lymphoma: Treatment Updates
Lymphoma: Treatment UpdatesLymphoma: Treatment Updates
Lymphoma: Treatment Updatesspa718
 
Indolent lymphoma-Management
Indolent lymphoma-Management Indolent lymphoma-Management
Indolent lymphoma-Management Nabeel Yahiya
 
acute and chronic Leukemia therapy by irfan hamid
 acute and chronic Leukemia  therapy by irfan hamid acute and chronic Leukemia  therapy by irfan hamid
acute and chronic Leukemia therapy by irfan hamidayeshahmed786
 
9 Tumor+Chemotherapy English +Version Imp
9   Tumor+Chemotherapy English  +Version Imp9   Tumor+Chemotherapy English  +Version Imp
9 Tumor+Chemotherapy English +Version ImpSumit Prajapati
 
Staining of Circulating Tumor Cells - as easy as a blood picture
Staining of Circulating Tumor Cells - as easy as a blood pictureStaining of Circulating Tumor Cells - as easy as a blood picture
Staining of Circulating Tumor Cells - as easy as a blood picturePeter Pachmann
 

Viewers also liked (9)

Dr Corinna Hawkes - World Cancer Congress - Policy panel presentation
Dr Corinna Hawkes - World Cancer Congress - Policy panel presentationDr Corinna Hawkes - World Cancer Congress - Policy panel presentation
Dr Corinna Hawkes - World Cancer Congress - Policy panel presentation
 
Lymphoma: Treatment Updates
Lymphoma: Treatment UpdatesLymphoma: Treatment Updates
Lymphoma: Treatment Updates
 
How Young Adults Cope with Lymphoma
How Young Adults Cope with LymphomaHow Young Adults Cope with Lymphoma
How Young Adults Cope with Lymphoma
 
Indolent lymphoma-Management
Indolent lymphoma-Management Indolent lymphoma-Management
Indolent lymphoma-Management
 
An Overview of Lymphoma Treatment
An Overview of Lymphoma TreatmentAn Overview of Lymphoma Treatment
An Overview of Lymphoma Treatment
 
acute and chronic Leukemia therapy by irfan hamid
 acute and chronic Leukemia  therapy by irfan hamid acute and chronic Leukemia  therapy by irfan hamid
acute and chronic Leukemia therapy by irfan hamid
 
9 Tumor+Chemotherapy English +Version Imp
9   Tumor+Chemotherapy English  +Version Imp9   Tumor+Chemotherapy English  +Version Imp
9 Tumor+Chemotherapy English +Version Imp
 
Staining of Circulating Tumor Cells - as easy as a blood picture
Staining of Circulating Tumor Cells - as easy as a blood pictureStaining of Circulating Tumor Cells - as easy as a blood picture
Staining of Circulating Tumor Cells - as easy as a blood picture
 
MASTER_ SC
MASTER_ SCMASTER_ SC
MASTER_ SC
 

Similar to How Maintenance Therapy Is Used in Lymphoma

Cancer chemotherapy- General Introductionpptx
Cancer chemotherapy- General IntroductionpptxCancer chemotherapy- General Introductionpptx
Cancer chemotherapy- General IntroductionpptxAbarna Ravi
 
Metastatic bc research
Metastatic bc researchMetastatic bc research
Metastatic bc researchnelsonusnayo
 
Basic Pharmacology
Basic PharmacologyBasic Pharmacology
Basic Pharmacologyflasco_org
 
Principles of cancer chemotherapy and its clinical evaluation
Principles of cancer chemotherapy and its clinical evaluationPrinciples of cancer chemotherapy and its clinical evaluation
Principles of cancer chemotherapy and its clinical evaluationjyotimannath
 
Targeted therapy.ppt
Targeted therapy.pptTargeted therapy.ppt
Targeted therapy.pptuditnarang
 
DOSTARLIMAB
DOSTARLIMABDOSTARLIMAB
DOSTARLIMABZoha58
 
Chemotherapy of Head and neck cancers seminar
Chemotherapy of Head and neck cancers seminarChemotherapy of Head and neck cancers seminar
Chemotherapy of Head and neck cancers seminarMammootty Ik
 
principles of chemotherapy
principles of chemotherapyprinciples of chemotherapy
principles of chemotherapyDR NILESH KATOLE
 
Pharmacology in ent ii anticancer drugs dr rk
Pharmacology in ent  ii anticancer drugs dr rkPharmacology in ent  ii anticancer drugs dr rk
Pharmacology in ent ii anticancer drugs dr rkraju kafle
 
Principles of cancer cheotherapy by Dr Deenadayalan MD.,DM(Onco),Madurai.
Principles of cancer cheotherapy by Dr Deenadayalan MD.,DM(Onco),Madurai.Principles of cancer cheotherapy by Dr Deenadayalan MD.,DM(Onco),Madurai.
Principles of cancer cheotherapy by Dr Deenadayalan MD.,DM(Onco),Madurai.Dr DEENADAYALAN T
 
Principles of chemotherapy in Gynecologic oncology
Principles of chemotherapy in Gynecologic oncologyPrinciples of chemotherapy in Gynecologic oncology
Principles of chemotherapy in Gynecologic oncologyWonduBelayneh
 
Immunoregulation For Long-Term Cancer Control Case Study
Immunoregulation For Long-Term Cancer Control Case StudyImmunoregulation For Long-Term Cancer Control Case Study
Immunoregulation For Long-Term Cancer Control Case StudyShannon Gutierrez
 

Similar to How Maintenance Therapy Is Used in Lymphoma (20)

Chemotherapeutic agents
Chemotherapeutic agentsChemotherapeutic agents
Chemotherapeutic agents
 
Cancer chemotherapy- General Introductionpptx
Cancer chemotherapy- General IntroductionpptxCancer chemotherapy- General Introductionpptx
Cancer chemotherapy- General Introductionpptx
 
Mesotheliomahelp org treatment_chemotherapy
Mesotheliomahelp org treatment_chemotherapyMesotheliomahelp org treatment_chemotherapy
Mesotheliomahelp org treatment_chemotherapy
 
Fundamentals of chemotherapy
Fundamentals of chemotherapyFundamentals of chemotherapy
Fundamentals of chemotherapy
 
Metastatic bc research
Metastatic bc researchMetastatic bc research
Metastatic bc research
 
Basic Pharmacology
Basic PharmacologyBasic Pharmacology
Basic Pharmacology
 
Principles of cancer chemotherapy and its clinical evaluation
Principles of cancer chemotherapy and its clinical evaluationPrinciples of cancer chemotherapy and its clinical evaluation
Principles of cancer chemotherapy and its clinical evaluation
 
Targeted therapy.ppt
Targeted therapy.pptTargeted therapy.ppt
Targeted therapy.ppt
 
DOSTARLIMAB
DOSTARLIMABDOSTARLIMAB
DOSTARLIMAB
 
Chemotherapy
ChemotherapyChemotherapy
Chemotherapy
 
Principles of chemotherapy .pdf
Principles of chemotherapy .pdfPrinciples of chemotherapy .pdf
Principles of chemotherapy .pdf
 
Chemotherapy.pptx
Chemotherapy.pptxChemotherapy.pptx
Chemotherapy.pptx
 
Chemotherapy of Head and neck cancers seminar
Chemotherapy of Head and neck cancers seminarChemotherapy of Head and neck cancers seminar
Chemotherapy of Head and neck cancers seminar
 
principles of chemotherapy
principles of chemotherapyprinciples of chemotherapy
principles of chemotherapy
 
Pharmacology in ent ii anticancer drugs dr rk
Pharmacology in ent  ii anticancer drugs dr rkPharmacology in ent  ii anticancer drugs dr rk
Pharmacology in ent ii anticancer drugs dr rk
 
Neoadjuvant treatment for esophageal and gastric cancer
Neoadjuvant treatment for esophageal and gastric cancerNeoadjuvant treatment for esophageal and gastric cancer
Neoadjuvant treatment for esophageal and gastric cancer
 
Principles of cancer cheotherapy by Dr Deenadayalan MD.,DM(Onco),Madurai.
Principles of cancer cheotherapy by Dr Deenadayalan MD.,DM(Onco),Madurai.Principles of cancer cheotherapy by Dr Deenadayalan MD.,DM(Onco),Madurai.
Principles of cancer cheotherapy by Dr Deenadayalan MD.,DM(Onco),Madurai.
 
Cancer Treatment
Cancer TreatmentCancer Treatment
Cancer Treatment
 
Principles of chemotherapy in Gynecologic oncology
Principles of chemotherapy in Gynecologic oncologyPrinciples of chemotherapy in Gynecologic oncology
Principles of chemotherapy in Gynecologic oncology
 
Immunoregulation For Long-Term Cancer Control Case Study
Immunoregulation For Long-Term Cancer Control Case StudyImmunoregulation For Long-Term Cancer Control Case Study
Immunoregulation For Long-Term Cancer Control Case Study
 

More from Dana-Farber Cancer Institute

Personal Finance Tips for Young Adults with Cancer
Personal Finance Tips for Young Adults with Cancer Personal Finance Tips for Young Adults with Cancer
Personal Finance Tips for Young Adults with Cancer Dana-Farber Cancer Institute
 
How are Adult and Childhood Leukemia Alike and Different?
How are Adult and Childhood Leukemia Alike and Different?How are Adult and Childhood Leukemia Alike and Different?
How are Adult and Childhood Leukemia Alike and Different?Dana-Farber Cancer Institute
 
Research in the Program for Young Women with Breast Cancer: Past, Present and...
Research in the Program for Young Women with Breast Cancer: Past, Present and...Research in the Program for Young Women with Breast Cancer: Past, Present and...
Research in the Program for Young Women with Breast Cancer: Past, Present and...Dana-Farber Cancer Institute
 
Clinical Trials for Metastatic HER2-positive Breast Cancer
Clinical Trials for Metastatic HER2-positive Breast CancerClinical Trials for Metastatic HER2-positive Breast Cancer
Clinical Trials for Metastatic HER2-positive Breast CancerDana-Farber Cancer Institute
 
Surgery for Inflammatory Breast Cancer: How and Why
Surgery for Inflammatory Breast Cancer: How and WhySurgery for Inflammatory Breast Cancer: How and Why
Surgery for Inflammatory Breast Cancer: How and WhyDana-Farber Cancer Institute
 
Primary Systemic Therapy for Inflammatory Breast Cancer
Primary Systemic Therapy for Inflammatory Breast CancerPrimary Systemic Therapy for Inflammatory Breast Cancer
Primary Systemic Therapy for Inflammatory Breast CancerDana-Farber Cancer Institute
 
7 Ways Integrative Therapies Can Help Cancer Patients
7 Ways Integrative Therapies Can Help Cancer Patients7 Ways Integrative Therapies Can Help Cancer Patients
7 Ways Integrative Therapies Can Help Cancer PatientsDana-Farber Cancer Institute
 

More from Dana-Farber Cancer Institute (20)

Exercise Tips for Cancer Patients
Exercise Tips for Cancer Patients Exercise Tips for Cancer Patients
Exercise Tips for Cancer Patients
 
Personal Finance Tips for Young Adults with Cancer
Personal Finance Tips for Young Adults with Cancer Personal Finance Tips for Young Adults with Cancer
Personal Finance Tips for Young Adults with Cancer
 
5 Things to Know About Glioblastomas
5 Things to Know About Glioblastomas5 Things to Know About Glioblastomas
5 Things to Know About Glioblastomas
 
How are Adult and Childhood Leukemia Alike and Different?
How are Adult and Childhood Leukemia Alike and Different?How are Adult and Childhood Leukemia Alike and Different?
How are Adult and Childhood Leukemia Alike and Different?
 
Research in the Program for Young Women with Breast Cancer: Past, Present and...
Research in the Program for Young Women with Breast Cancer: Past, Present and...Research in the Program for Young Women with Breast Cancer: Past, Present and...
Research in the Program for Young Women with Breast Cancer: Past, Present and...
 
Clinical Trials for Metastatic HER2-positive Breast Cancer
Clinical Trials for Metastatic HER2-positive Breast CancerClinical Trials for Metastatic HER2-positive Breast Cancer
Clinical Trials for Metastatic HER2-positive Breast Cancer
 
Healthy Living After A Breast Cancer Diagnosis
Healthy Living After A Breast Cancer DiagnosisHealthy Living After A Breast Cancer Diagnosis
Healthy Living After A Breast Cancer Diagnosis
 
Signs and Symptoms of Prostate Cancer
Signs and Symptoms of Prostate CancerSigns and Symptoms of Prostate Cancer
Signs and Symptoms of Prostate Cancer
 
6 Common Types of Pediatric Brain Tumors
6 Common Types of Pediatric Brain Tumors6 Common Types of Pediatric Brain Tumors
6 Common Types of Pediatric Brain Tumors
 
Soft Tissue Sarcomas: Symptoms and Risk Factors
Soft Tissue Sarcomas: Symptoms and Risk FactorsSoft Tissue Sarcomas: Symptoms and Risk Factors
Soft Tissue Sarcomas: Symptoms and Risk Factors
 
10 Tips for Easing Chemo-Related Fatigue
10 Tips for Easing Chemo-Related Fatigue10 Tips for Easing Chemo-Related Fatigue
10 Tips for Easing Chemo-Related Fatigue
 
Surgery for Inflammatory Breast Cancer: How and Why
Surgery for Inflammatory Breast Cancer: How and WhySurgery for Inflammatory Breast Cancer: How and Why
Surgery for Inflammatory Breast Cancer: How and Why
 
Radiation Therapy for Inflammatory Breast Cancer
Radiation Therapy for Inflammatory Breast CancerRadiation Therapy for Inflammatory Breast Cancer
Radiation Therapy for Inflammatory Breast Cancer
 
Primary Systemic Therapy for Inflammatory Breast Cancer
Primary Systemic Therapy for Inflammatory Breast CancerPrimary Systemic Therapy for Inflammatory Breast Cancer
Primary Systemic Therapy for Inflammatory Breast Cancer
 
What Cancers Should Men Be Screened For?
What Cancers Should Men Be Screened For?What Cancers Should Men Be Screened For?
What Cancers Should Men Be Screened For?
 
Five Common Types of Brain Tumors
Five Common Types of Brain TumorsFive Common Types of Brain Tumors
Five Common Types of Brain Tumors
 
Signs and Symptoms of Multiple Myeloma
Signs and Symptoms of Multiple MyelomaSigns and Symptoms of Multiple Myeloma
Signs and Symptoms of Multiple Myeloma
 
7 Ways Integrative Therapies Can Help Cancer Patients
7 Ways Integrative Therapies Can Help Cancer Patients7 Ways Integrative Therapies Can Help Cancer Patients
7 Ways Integrative Therapies Can Help Cancer Patients
 
Five Things You Need to Know About Colon Cancer
Five Things You Need to Know About Colon CancerFive Things You Need to Know About Colon Cancer
Five Things You Need to Know About Colon Cancer
 
What You Should Know About Cervical Cancer
What You Should Know About Cervical CancerWhat You Should Know About Cervical Cancer
What You Should Know About Cervical Cancer
 

Recently uploaded

CANCER SeminarCancer Overview Type of Cancer.pptx
CANCER SeminarCancer Overview  Type of Cancer.pptxCANCER SeminarCancer Overview  Type of Cancer.pptx
CANCER SeminarCancer Overview Type of Cancer.pptxMrStavanUdayKadam
 
Derma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech LimitedDerma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech LimitedSBL DIGITAL
 
The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...JakeMatthews12
 
Brief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxBrief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxTina Purnat
 
SMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxSMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxAbdirahmanWaseem
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUKanhu Charan
 
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...Genesis Institute of Pharmacy, Radhanagari.
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)chahattyagi200
 
SGK PHÙ PHỔI CẤP ĐHYHN .pdf
SGK PHÙ PHỔI CẤP ĐHYHN                   .pdfSGK PHÙ PHỔI CẤP ĐHYHN                   .pdf
SGK PHÙ PHỔI CẤP ĐHYHN .pdfHongBiThi1
 
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKLaryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKQuick MedTalk
 
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptKavitha Krishnan
 
Ten lessons learnt as anesthetist.pptx
Ten  lessons  learnt as anesthetist.pptxTen  lessons  learnt as anesthetist.pptx
Ten lessons learnt as anesthetist.pptxtusharchokshi1
 
bleeding disorders 1 Dr.Nannika Pradhan
bleeding disorders 1  Dr.Nannika Pradhanbleeding disorders 1  Dr.Nannika Pradhan
bleeding disorders 1 Dr.Nannika Pradhanthesalberry
 
Reproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptxReproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptxVeereshDemashetti
 
Explaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyExplaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyYves Sucaet
 
Neutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsNeutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsPradnya Wadekar
 
Thyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptxThyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptxRajendra Dev Bhatt
 
Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......anupamdas2143
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHUKanhu Charan
 

Recently uploaded (20)

CANCER SeminarCancer Overview Type of Cancer.pptx
CANCER SeminarCancer Overview  Type of Cancer.pptxCANCER SeminarCancer Overview  Type of Cancer.pptx
CANCER SeminarCancer Overview Type of Cancer.pptx
 
Derma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech LimitedDerma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech Limited
 
The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...
 
Brief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxBrief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptx
 
SMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxSMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptx
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
 
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)
 
SGK PHÙ PHỔI CẤP ĐHYHN .pdf
SGK PHÙ PHỔI CẤP ĐHYHN                   .pdfSGK PHÙ PHỔI CẤP ĐHYHN                   .pdf
SGK PHÙ PHỔI CẤP ĐHYHN .pdf
 
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKLaryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
 
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
 
Oral disorders .pptx
Oral disorders .pptxOral disorders .pptx
Oral disorders .pptx
 
Ten lessons learnt as anesthetist.pptx
Ten  lessons  learnt as anesthetist.pptxTen  lessons  learnt as anesthetist.pptx
Ten lessons learnt as anesthetist.pptx
 
bleeding disorders 1 Dr.Nannika Pradhan
bleeding disorders 1  Dr.Nannika Pradhanbleeding disorders 1  Dr.Nannika Pradhan
bleeding disorders 1 Dr.Nannika Pradhan
 
Reproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptxReproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptx
 
Explaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyExplaining "pathology" in digital pathology
Explaining "pathology" in digital pathology
 
Neutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsNeutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractions
 
Thyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptxThyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptx
 
Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
 

How Maintenance Therapy Is Used in Lymphoma

  • 1. The Role of Maintenance Therapy in Lymphoma Arnie Freedman, M.D. Clinical Director, Dana-Farber/Brigham and Women’s Cancer Center Adult Lymphoma Program
  • 2. Maintenance the process of maintaining or preserving someone or something, or the state of being maintained. synonyms: preservation, conservation, keeping, prolongation, perpetuation, carry on, continuation.
  • 3. Maintenance therapy for lymphoma Use an effective therapy after remission is attained, to maintain that remission and hopefully increase survival, without increased toxicity, both early and late.
  • 4. Maintenance therapy What is the goal ? maintaining remission improving survival What disease ? What drug to use ?
  • 5. Maintenance therapy What are the endpoints and what disease ? (goals: remission, survival, both) For aggressive disease, remission and survival easier to demonstrate. For indolent disease, survival benefit harder to prove.
  • 6. Maintenance therapy What drug to use ? has to be effective by itself against the disease. benefits have to outweigh the side effects and risks.
  • 7. Drug choices Has anyone taken chlorambucil for long time? Chemotherapy (chlorambucil) Pros effective agent, convenient (oral), no hair loss, minimal nausea. Cons: lowers blood counts, toxic to stem cells, risk of malignancy (solid tumor, leukemia).
  • 8. Drug choices Has anyone taken interferon ? Interferon-a Pros “immunotherapy” Cons: minimal anti-lymphoma activity, some inconvenience (inject), flu like symptoms
  • 9. Drug choices Raise your hand if you have had rituximab maintenance ? Rituximab Pros effective agent, some inconvenience (I.V.) Cons: infusion reactions, infection risk
  • 10. Maintenance studies (randomized) Past CLL, follicular NHL (chemotherapy, interferon) Present DLBCL, follicular NHL, MCL (rituximab) Future DLBCL, Hodgkin’s, others (small molecules, antibody-drug conjugates)
  • 11. Maintenance: the past Chlorambucil maintenance for CLL No advantage in survival Myelosuppression More second malignancies (AML/MDS/solid tumors)
  • 12. Maintenance: the past Interferon maintenance for follicular NHL Chemotherapy followed by maintenance or none. Longer remissions, no advantage in survival. Poor tolerance, compliance. Never adopted in U.S.A.
  • 13. Maintenance: the present Rituximab maintenance for follicular NHL Longer remissions after chemotherapy, chemoimmunotherapy, rituximab alone. No increased survival (yet). Reasonably well tolerated, increased viral infections. Well adopted in U.S.A.
  • 14. Maintenance: the present Rituximab maintenance for DLBCL, MCL. For MCL but not DLBCL, longer remissions after chemoimmunotherapy. Improved survival for MCL. Well tolerated, but maintenance is indefinite (MCL study).
  • 15. Maintenance: the future Should maintenance be pursued? Generally has not worked well (rituximab is the exception). Wrong drug choice, wrong disease, hard to study (compliance and safety). Will new effective drugs work as maintenance? ADC (brentuximab), oral kinase inhibitors
  • 16. Maintenance: the future Enzastaurin (oral kinase inhibitor) Maintenance for DLBCL No benefit Marginally effective drug Induction prior to maintenance more effective than in past.
  • 17. Maintenance: the future Brentuximab (antibody drug conjugate) Maintenance for Hodgkin lymphoma post autoSCT. Oral kinase inhibitors being studied for example, idelalisib for follicular NHL